VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 3 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $585,000 | +11600.0% | 25,160 | +12480.0% | 0.02% | – |
| Q1 2016 | $5,000 | -75.0% | 200 | 0.0% | 0.00% | – |
| Q4 2015 | $20,000 | -97.6% | 200 | -95.7% | 0.00% | -100.0% |
| Q3 2015 | $838,000 | -19.7% | 4,700 | 0.0% | 0.01% | -6.7% |
| Q2 2015 | $1,044,000 | +11.8% | 4,700 | 0.0% | 0.02% | +7.1% |
| Q1 2015 | $934,000 | +14.5% | 4,700 | -17.5% | 0.01% | +16.7% |
| Q4 2014 | $816,000 | +9.1% | 5,700 | 0.0% | 0.01% | +9.1% |
| Q3 2014 | $748,000 | +4.0% | 5,700 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $719,000 | -4.3% | 5,700 | 0.0% | 0.01% | -8.3% |
| Q1 2014 | $751,000 | – | 5,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |